Moreover, Calpeptin, an inhibitor of the p35 protein cleavage enzyme Calpain [53], significantly reverses RA-induced p25 overactivation of CDK5 while p35 protein expression is maintained in human prostate cancer cells and RA-triggered apoptosis is also prevented [3]. This evidence concerns the gene CDK5 and prostate carcinoma.